Form 4 for NRIX Nurix Therapeutics, Inc.
Accepted 2024-11-04 00:00:00 ET · period of report 2024-11-04 · accession 0001549595-24-000156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-04 | 2024-11-04 | NRIX | Ring Christine | CLO | S - Sale+OE | $25.00 | -3,290 | 28.1K | -10% | -$82.2K |
| D | 2024-11-04 | 2024-11-04 | NRIX | Ring Christine | CLO | M - OptEx | $9.57 | +3,290 | 31.4K | +12% | +$31.5K |
| D | 2024-11-04 | 2024-11-04 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | -3,290 | 96.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-04 | S | D | 3,290 | $25.00 | 28,084 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-04 | M | A | 3,290 | $9.57 | 31,374 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2024-11-04 | M | D | 3,290 | $0.00 | 96,389 | D | $9.57 · — to 2030-05-27 | 3,290 Common Stock | (F2) The stock option vested as to 1/48 of the total shares monthly beginning June 28, 2020, until the option was fully vested on May 28, 2024. |